title: GSK is fined £38m for delaying generic paroxetine.
authors.affiliation: The BMJ.
authors.forename: Clare
authors.initials: C
authors.lastname: Dyer
mesh_terms: D018687:Antidepressive Agents, Second-Generation / Q000627:therapeutic use*; D004345:Drug Industry / Q000331:legislation & jurisprudence*; D016568:Drugs, Generic; D004465:Economic Competition / Q000331:legislation & jurisprudence*; D006801:Humans; D017374:Paroxetine / Q000627:therapeutic use*; D028743:Professional Misconduct; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use*; D006113:United Kingdom
chemical_list: D018687:Antidepressive Agents, Second-Generation; D016568:Drugs, Generic; D017374:Paroxetine; D017367:Selective Serotonin Reuptake Inhibitors